Attached files
file | filename |
---|---|
EX-10.51 - EX-10.51 - Alexza Pharmaceuticals Inc. | f58240a1exv10w51.htm |
10-K/A - FORM 10-K/A - Alexza Pharmaceuticals Inc. | f58240a1e10vkza.htm |
EX-31.4 - EX-31.4 - Alexza Pharmaceuticals Inc. | f58240a1exv31w4.htm |
EX-31.3 - EX-31.3 - Alexza Pharmaceuticals Inc. | f58240a1exv31w3.htm |
Exhibit 32.2
CERTIFICATION
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of
1934, as amended (the Exchange Act), and Section 1350 of Chapter 63 of Title 18 of the United
States Code (18 U.S.C. § 1350), Thomas B. King, President and Chief Executive Officer of Alexza
Pharmaceuticals, Inc. (the Company), and August J. Moretti, the Senior Vice President and Chief
Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:
1. The Companys Annual Report on Form 10-K/A for the period ended December 31, 2010, to which
this Certification is attached as Exhibit 32.2 (the Annual Report), fully complies with the
requirements of Section 13(a) or Section 15(d) of the Exchange Act; and
2. The information contained in the Annual Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
In Witness Whereof, the undersigned have set their hands hereto as of the 28th day of April,
2011.
/s/ Thomas B. King
|
/s/ August J. Moretti
|
|||
President and Chief Executive Officer
|
Senior Vice President and Chief Financial Officer |
This certification accompanies the Form 10-K/A to which it relates, is not deemed filed with
the Securities and Exchange Commission and is not to be incorporated by reference into any filing
of Alexza Pharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities
Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K/A),
irrespective of any general incorporation language contained in such filing.